ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,534, issued on Jan. 27, was assigned to INVOX PHARMA Ltd. (London).
"Anti-CD137 antibodies" was invented by Sarka Pechouckova (Cambridge, Great Britain), Francisca Wollerton (Cambridge, Great Britain) and Miguel Gaspar (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to antibody molecules that bind CD137. The antibody molecules find application in the treatment and diagnosis of diseases and disorders, such as cancer and infectious diseases."
The patent was filed on July 12, 2019, under Application No. 17/259,680.
*For further information, including images, charts and tables, please visit: htt...